sanofi stock Archives

SAN Stock Up 0.52%, Sanofi to Begin Human Trials of Second COVID-19 Vaccine

Sanofi will begin testing its second COVID-19 vaccine on 415 people today. First results are expected sometime between July and September 2021.

Sanofi-GSK COVID-19 Vaccine Rollout Delayed Due to Low Efficacy with Older Patients

Business News, Market News, News, Stocks, Wall Street

By Steve Muchoki Dec 11, 2020

Apparently, Sanofi noted that the vaccine was more responsive to younger patients, particularly those below 49 years.

PRNB Stock Up 1% as Sanofi Mulls Buying Principia Biopharma for $50B

Business News, Deals News, Market News, News, Stocks

By Teuta Franjkovic Jul 17, 2020

Sanofi is looking at potential acquisitions of U.S. biotechnology companies including Principia Biopharma, as it looks for innovative treatments for clinical areas including multiple sclerosis and immune disorders. PRNB stock price is up.

Business News, Editor's Choice, Market News, News, Stocks

GlaxoSmithKline and Sanofi to Supply UK Government with 60M COVID-19 Vaccine Doses

By Darya Rudz Jul 6, 2020

Following the news, both Sanofi and GlaxoSmithKline stocks jumped. The latest closing price for Sanofi was $51.62. GlaxoSmithKline shares ended at $41.22 at the latest session.

Business News, Market News, News, Stocks

Coronavirus Vaccine Stocks: Top Biotech Companies to Invest In

By Darya Rudz May 18, 2020

Of course, there is always risk involved in investing, regardless of which industry or what kind of company it is. In the case of coronavirus vaccine stocks, you should bear in mind that not all of the vaccine candidates will be successful.

Business News, Market News, News, Stocks, Wall Street

Sanofi Stock Down 1.6%, Company Is Criticized for Giving U.S. Priority Access to Its Vaccine

By Steve Muchoki May 14, 2020

After closing yesterday with a 0.17% rise, Sanofi (SNY) stock is in the red now. “Giving the U.S. priority access to a Sanofi vaccine against the new coronavirus would be ‘unacceptable,’” a French government minister said.

Business News, Editor's Choice, Market News, News, Stocks

Pharma Giants Sanofi and GlaxoSmithKline Join Hands to Develop Coronavirus Vaccine

By Darya Rudz Apr 15, 2020

Within the partnership, Sanofi will contribute its S-protein COVID-19 antigen based on recombinant DNA technology, while GlaxoSmithKline will implement its proven pandemic adjuvant technology.

Business News, Market News, News, Stocks

5 Coronavirus Stocks to Look Out For as COVID-19 Spread Continues

By Tolu Ajiboye Apr 6, 2020

A few stocks, including some of the ones below, are being classified as COVID-19 stocks because of their potential to rise even as the pandemic worsens.